Top Markets
Coin of the day
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited

Lee's Pharmaceutical Holdings Limited

0950
Classifica tra le azioni #22620
Lee's Pharmaceutical Holdings Limited, an investment holding company, develops,... Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells Nadroparin Calcium injection and Livaracine to treat blood clots and deep vein thrombosis; Yallaferon for viral infection; Slounase for hemostasis; Socazolimab Injection for Recurrent or metastatic cervical cancer; Treprostinil injection for pulmonary arterial hypertension; fondaparinux sodium injection for deep vein thrombosis; and Sodium Phenylbutyrate Granules to treat urea cycle disorders; Apremilast Tablets for Plaque psoriasis; and Azilsartan Tablets for hypertension. The Licensed-In Products segment offers Sancuso for chemotherapy induced nausea and vomiting; Bredinin to treat Immunosuppression in renal transplantation; Centraxal Plus for acute otitis media with tympanostomy tubes; and Ferplex to treat iron deficiency anemia. This segment also offers Intrarosa for vulvovaginal atrophy; Adasuve for agitation associated with schizophrenia or bipolar I disorder in adults; Mictonorm for urinary incontinence; Natulan for Stage III and IV Hodgkin's disease; Lutrate for Prostate cancer; Nitric Oxide for Inhalation for Hypoxic respiratory failure associated with pulmonary hypertension; Omacor to treat Omega-3-acid ethyl esters; Zanidip for hypertension; Readyfusor for post-operative pain management; Teglutik to treat Amyotrophic lateral sclerosis; Trittico for insomnia/depression; Dicoflor and VSL#3 for probiotics; and Zingo for topical local analgesics. The company was founded in 1994 and is headquartered in Sha Tin, Hong Kong.
Prezzo delle azioni
$0.1458359
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$85.87M
Variazione (1 giorno)
-1.30%
Variazione (1 anno)
-38.40%
Paese
HK
Scambia Lee's Pharmaceutical Holdings Limited (0950)

Categoria

Storico del prezzo dell'azione per Lee's Pharmaceutical Holdings Limited (0950)
Prezzo di chiusura più alto: $0.14 il 2026-08-01

Prezzo di chiusura più basso: $0.06 il 2002-07-01
Storico del prezzo dell'azione di Lee's Pharmaceutical Holdings Limited dal 2002 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -8.02%
2025 23.34%
2024 -9.91%
2023 -13.69%
2022 -47.94%
2021 -28.30%
2020 15.21%
2019 -32.12%
2018 -11.05%
2017 -0.72%
2016 -26.55%
2015 -18.29%
2014 54.29%
2013 40.74%
2012 86.12%
2011 -26.69%
2010 121.83%
2009 325.22%
2008 -22.69%
2007 122.43%
2006 10.34%
2005 3.13%
2004 -43.96%
2003 -4.61%
2002 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$61.28 68.71%
US
$51.38 67.85%
SE
$193.82 41.69%
FR
$120.88 71.87%
US
$62.69 1.96%
IT